Publications by authors named "Marco Panzavolta"

Background: Single-inflow coronary bypass through left internal thoracic artery and Y graft is effective in myocardial revascularization, but left sublavian diseases may affect its safety.

Aim Of The Study: To assess that, in presence of a composite Y graft, issues involving the origin of the left internal thoracic artery are relatively easy to manage, even in reoperations.

Methods: A critical stenosis of the subclavian artery involving the origin of a bilateral internal thoracic artery Y graft was bypassed using a free radial artery graft.

View Article and Find Full Text PDF

Background: This study compared perioperative results and mortality rates of different approaches to perform aortic valve replacement (AVR), describing predictors favoring one approach over the others.

Methods: All patients who underwent AVR were enrolled. The choice of the approach was left to surgeon's preference.

View Article and Find Full Text PDF

Objective: Minimally invasive surgery through an upper hemisternotomy for aortic valve replacement has become the routine approach with excellent results. Actually, the same minimally invasive access is used for complex ascending aorta procedures only in few centers. We report our experience with minimally invasive approach for aortic valve and ascending aorta replacement using Bentall technique.

View Article and Find Full Text PDF

Background: Details are provided of the authors' four-year experience with minimally invasive aortic valve replacement (AVR) through a right mini-thoracotomy, using totally central cannulation.

Methods: Between November 2011 and October 2014, a total of 248 patients (143 males, 105 females; mean age 72.6 ± 11.

View Article and Find Full Text PDF

Objectives: A multicentric European Clinical Study is ongoing to evaluate safety and efficacy of a new pulsatile implantable LVAD (BestBeat), smaller and lighter than similar devices, capable of providing synchronous and counterpulsating flow with respect to the LV of end-stage heart failure patients. Preliminary clinical results are reported.

Methods: The new BestBeat LVAD was used, consisting of an implantable pulsatile blood pump, electromechanically driven by a ball screw mechanism, and a wearable electronic controller and power sources.

View Article and Find Full Text PDF